Nephros (NEPH) vs NexGel (NXGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nephros is the larger company by market cap ($38.3 million vs $97,622), about 392.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEPH | NXGL |
|---|---|---|
| Share price | $3.53 | $0.2003 |
| Market cap | $38.34M | $97.62K |
| 1-day change | +7.29% | +33.53% |
| YTD return | -32.58% | — |
| 1-year return | -36.24% | — |
| 5-year return | -57.60% | — |
| P/E ratio (TTM) | 23.53 | — |
| Forward P/E | 16.81 | — |
| EPS (TTM) | $0.15 | $-14.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.42 | $57.00 |
| 52-week low | $2.66 | $0.151 |
| Distance from 52-week high | -45.02% | -99.65% |
| Analyst consensus | none | hold |
| Avg. price target upside | +77.05% | — |
| Average volume | 27.59K | 37.86K |
| Shares outstanding | 10.86M | 487.38K |
| Employees | 36 | 19 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nephros is about 392.7 times larger than NexGel by market value ($38.34M vs $97.62K).
About Nephros
NEPH stock →Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
Health Care · Medical/Dental Instruments · 36 employees
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
NEPH vs NXGL FAQ
Which is bigger, Nephros or NexGel?
Nephros (NEPH) is larger, with a market capitalization of $38.34M compared with $97.62K for NexGel (NXGL).
Are Nephros and NexGel in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.